Community intervention programs prolong the onset of functional disability among older Japanese.


Journal

Geriatrics & gerontology international
ISSN: 1447-0594
Titre abrégé: Geriatr Gerontol Int
Pays: Japan
ID NLM: 101135738

Informations de publication

Date de publication:
Jun 2022
Historique:
revised: 28 02 2022
received: 07 10 2021
accepted: 15 03 2022
pubmed: 23 4 2022
medline: 7 6 2022
entrez: 22 4 2022
Statut: ppublish

Résumé

This study examined the effects of a "community-based center" intervention to prevent the onset of functional disability among residents in disaster-affected areas. We used data from a prospective cohort study conducted from 2010 to 2016 in Iwanuma City, Japan. Participants were community-dwelling independent adults aged ≥65 years. The exposure variable was the experience of using a community-based center. The outcome variable was functional disability onset. The average treatment effect on the treated (ATET) was estimated by adjusting for possible confounders. Additional analysis stratified by sex was conducted considering the sex differences in social participation rates. Among 3794 participants (mean ± SD age = 72.9 ±5.3 years, 46.0% men), 196 (5.2%) used the community-based center, and 849 (22.4%) exhibited disability onset. Of those with functional disabilities, 40 (20.4%) used the community-based center, while 809 (22.5%) did not. The ATET for functional disability onset with community-based center activities across all participants were not significant (ATET: 0.51 years [95% confidence interval [CI] = -0.23; 1.27]). However, the direction of the effect of community-based center activities differed by sex (ATET: -0.14, 95% CI = -2.59; 2.31 for men [n = 18], and 0.66, 95% CI = 0.18; 1.16 for women [n = 178]). Women exhibited a 15.63% (95% CI = 3.58; 27.68) increase in the time until functional disability onset. The use of community-based centers was associated with a longer period without functional disability in women. Geriatr Gerontol Int 2022; 22: 465-470.

Identifiants

pubmed: 35451194
doi: 10.1111/ggi.14385
pmc: PMC9167703
mid: NIHMS1800883
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

465-470

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP20K18820
Organisme : Japan Society for the Promotion of Science
ID : JP18390200
Organisme : Japan Society for the Promotion of Science
ID : P15H04781
Organisme : Japan Society for the Promotion of Science
ID : JP15H01972
Organisme : Japan Society for the Promotion of Science
ID : JP19H03860
Organisme : NIH HHS
ID : 5R01AG042463-07
Pays : United States
Organisme : Japan Society for the Promotion of Science
ID : JP24390469
Organisme : Ministry of Education, Culture, Sports, Science, and Technology
Organisme : Japan Society for the Promotion of Science
ID : JP16K12964
Organisme : Japan Society for the Promotion of Science
ID : JP22592327
Organisme : Japan Society for the Promotion of Science
ID : JP16H05556
Organisme : Japan Society for the Promotion of Science
ID : JP19K24060
Organisme : NIH HHS
ID : R01AG042463
Pays : United States
Organisme : Ministry of Health, Labour and Welfare
Organisme : MEXT-Supported Program for the Strategic Research Foundation at Private Universities
ID : 2009-2013
Organisme : NIA NIH HHS
ID : R01 AG042463
Pays : United States
Organisme : Health Labour Sciences Research Grant,Comprehensive Research on Aging and Health
ID : H22-Choju-Shitei-008
Organisme : Japan Society for the Promotion of Science
ID : JP22390400
Organisme : Research Foundation
Organisme : National Institutes of Health, US
Organisme : Japan Society for the Promotion of Science
ID : JP23243070

Informations de copyright

© 2022 The Authors. Geriatrics & Gerontology International published by John Wiley & Sons Australia, Ltd on behalf of Japan Geriatrics Society.

Références

Lancet. 2002 Jul 20;360(9328):252-4
pubmed: 12133675
J Gerontol A Biol Sci Med Sci. 2003 Oct;58(10):M954-9
pubmed: 14570865
Alzheimers Dement (N Y). 2016 Dec 21;3(1):23-32
pubmed: 29067317
SSM Popul Health. 2019 Jun 22;8:100424
pubmed: 31312713
BMJ Open. 2019 Oct 16;9(10):e023543
pubmed: 31619410
Am J Epidemiol. 2019 Jun 1;188(6):1109-1119
pubmed: 30874714
Arch Gen Psychiatry. 2012 Oct;69(10):1073-9
pubmed: 23026957
Am J Health Promot. 2007 Mar-Apr;21(4):237-47
pubmed: 17375489
BMC Geriatr. 2017 Aug 15;17(1):182
pubmed: 28814271
Geriatr Gerontol Int. 2022 Jun;22(6):465-470
pubmed: 35451194
Ageing Res Rev. 2015 Jul;22:39-57
pubmed: 25956016
Bull World Health Organ. 2019 Aug 01;97(8):570-574
pubmed: 31384075
BMJ Open. 2019 Mar 30;9(3):e024439
pubmed: 30928931
BMC Geriatr. 2017 Dec 29;17(1):297
pubmed: 29284406
Soc Sci Med. 2019 Nov;240:112527
pubmed: 31563760
Prev Med. 2016 Aug;89:121-128
pubmed: 27235600
J Epidemiol Community Health. 2015 Sep;69(9):905-10
pubmed: 25888596
BMC Public Health. 2015 May 23;15:503
pubmed: 26002342
J Am Med Dir Assoc. 2018 Jun;19(6):535-540.e1
pubmed: 29656837
J Gerontol B Psychol Sci Soc Sci. 2018 Jun 14;73(5):799-806
pubmed: 27194753
J Am Geriatr Soc. 2012 Feb;60(2):338-43
pubmed: 22211817
Cien Saude Colet. 2019 Sep 09;24(9):3275-3282
pubmed: 31508748
BMC Geriatr. 2018 Sep 21;18(1):224
pubmed: 30241507
J Am Geriatr Soc. 2011 Feb;59(2):200-6
pubmed: 21275933
Am J Epidemiol. 2003 Apr 1;157(7):633-42
pubmed: 12672683

Auteurs

Takafumi Yamamoto (T)

Department of Health Promotion, National Institute of Public Health, Saitama, Japan.

Hiroyuki Hikichi (H)

Division of Public Health, Kitasato University School of Medicine, Sagamihara, Japan.

Katsunori Kondo (K)

Center for Preventive Medical Sciences, Chiba University, Chiba, Japan.
Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Obu, Japan.

Ken Osaka (K)

Department of International and Community Oral Health, Tohoku University Graduate School of Dentistry, Sendai, Japan.

Jun Aida (J)

Department of Oral Health Promotion, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH